Connect with us

Health

Greg Bishop, Attorney of Park City, Discusses Intermittent Fasting During Retirement

mm

Published

on

Intermittent fasting – currently in vogue in many diet and health circles – describes different approaches to fasting. As the term implies, intermittent fasting refers to periodically abstaining from food and drink (although water and non-caloric drinks are acceptable). There are several different categories of intermittent fasting, but the three most common are (1) time-restricted feeding, (2) alternate-day fasting, and (3) periodic fasting.

Time-restricted feeding refers to eating only within a prescribed block of time each day. For example, one common approach is the 16:8 diet, where you fast continuously for 16 hours and then eat only during an 8-hour block of time (such as between 11:00 AM and 7:00 PM). The frequency of eating during that block of time – for example, 2 big meals versus 3 smaller meals with snacks – is largely a matter of personal preference.

Alternate-day fasting involves rotating between “fast days” and “feast days.” Under this method, a “fast day” can be thought of either as strict fasting (no food and only non-caloric drinks) or as limited to 25% of your normal daily caloric intake. A “feast day,” on the other hand, refers to a regular day of eating your normal caloric intake (in other words, the fast day does not offset going calorie crazy on the feast day).

Finally, periodic fasting is similar to alternate-day fasting in that it can refer to any occasional fasting for 24 or more consecutive hours, followed by a normal eating period. The 5:2 diet is an example of a common periodic fasting diet – eating five days each week and fasting on two non-consecutive days.

What’s the Point of Intermittent Fasting?

Attorney Greg Bishop, located in Park City, Utah, explains that the primary purposes of intermittent fasting are to lose weight and improve health. He notes that a December 2019 article published in the New England Journal of Medicine concludes that studies and clinical trials have demonstrated that intermittent fasting:

  • Is as effective for weight loss as standard diets (according to 6 short-term studies involving overweight or obese adults);
  • Promotes fat loss while maintaining muscle mass in those involved in resistance training;
  • Reduces the health risks associated with obesity, diabetes, cardiovascular disease, cancers and neurologic disorders;
  • Improves multiple indicators of cardiovascular health, including blood pressure, resting heart rate, HDL and LDL cholesterol levels, and insulin resistance;
  • Increases neuronal stress resistance through multiple mechanisms, including bolstering antioxidant defenses and DNA repair;
  • Suppresses inflammation, which can be beneficial in treating rheumatoid arthritis; and
  • Increases verbal memory, executive function, global cognition and working memory.

Notwithstanding the growing evidence from clinical studies regarding the health benefits of intermittent fasting, there is still much that we do not know. For example, most of the clinical studies were short-term, conducted over a matter of months. Thus, the long-term impacts of intermittent fasting are not yet known. Similarly, most of the study participants were overweight young- and middle-aged adults. It remains to be seen whether the benefits demonstrated in these short-term trials of young- and middle-aged adults also apply to older adults over the long term.

In addition, even if the benefits were conclusively established, it will likely take time for people so ingrained in a culture of eating three meals per day (plus snacks) to make the transition to some form of intermittent fasting. Moreover, some may find fasting difficult because of early symptoms of hunger, irritability and reduced ability to concentrate (which should subside within a month).

About Greg Bishop, Attorney | Greg Bishop is a Park City, Utah-based attorney with extensive experience in litigation, corporate work, M&A, licensing, IPO preparation, and HR, as well as corporate and board governance. Personally, he is passionate about helping others, including spending seven years working closely with the largest organization helping the homeless in Washington, D.C. In his free time, he enjoys the outdoors, mountain biking and traveling, as well as helping others achieve personal and professional success.

Michelle has been a part of the journey ever since Bigtime Daily started. As a strong learner and passionate writer, she contributes her editing skills for the news agency. She also jots down intellectual pieces from categories such as science and health.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

BioLongevity Labs: How Two Biohackers Are Making Longevity Safe for the Mainstream

mm

Published

on

Humans have been looking for ways to extend their lifespan for hundreds of years. Medicine has made impressive strides, but for many, the effects of aging are still painfully real.

Through BioLongevity Labs, biohackers and entrepreneurs Jay Campbell and Josh Felber aim to introduce ordinary people to potentially life-changing compounds called peptides. Campbell and Felber come from very different backgrounds.

Campbell is a five-time international bestselling author and globally recognized leader in the health-optimization space. Felber is a serial entrepreneur who excels at scaling businesses.

For both men, BioLongevity Labs is more than just a business venture — it’s about helping everyday people discover something that just might prolong and improve their lives.

“Your body inevitably changes as the years pile on,” says Campbell. “Your energy drops, and wrinkles start showing up uninvited. Peptides can change everything.”

Many people have probably heard the term “peptide” in passing. Some may know they’re associated with longevity. Most people just don’t have a strong grasp of how they work.

A peptide is a short chain of amino acids, which are the building blocks of proteins. Essentially, peptides are like shorter, simpler proteins. That might sound unremarkable, but the real magic of peptides lies in how they work.

They function as signaling or “messenger” molecules telling the body to perform specific functions. Many peptides function similarly to hormones. A relevant example is GLP-1 (glucagon-like peptide-1) receptor agonists. This class of medications includes semaglutide and tirzepatide, two wildly popular weight-loss drugs.

“These peptides aren’t just another biohacking fad,” Campbell explains. “They enhance insulin secretion and suppress glucagon release to balance blood sugar levels and promote sustainable weight loss”. But what sets GLP-1 receptor agonists apart is their ability to regulate hunger.

Through the reduction of appetite and increased feelings of fullness, it is far easier for dieters to stick to a calorie deficit.” Although GLP-1 receptor agonists are widely prescribed, most peptides aren’t.

Campbell asserts, because many peptides have the potential to cure illnesses by treating the fundamental root cause, they go against America’s “sick care” model of healthcare. They potentially threaten drug companies and their bottom line.

“Peptides are simultaneously a dream come true for mankind and the worst possible nightmare for the pharmaceutical industry,” says Campbell. “It’s not a conspiracy theory. It’s pure economics and psychology in action. People will do whatever it takes to make as much money as possible in a free-market society, even if it means suppressing a superior solution.”

Patients probably aren’t going to be introduced to peptides through the healthcare system. Many discover them on their own. But for the many people who don’t have a solid understanding of how they work molecularly or even what dose to take, there is a risk. That’s precisely what BioLongevity Labs’ co-founders are attempting to address.

Jay Campbell has dedicated his life to educating people about therapeutic peptides and optimized hormones, and along with his partner Josh Felber, they’ve created a company offering filler-free, third-party tested peptides and bioregulators.

Campbell and Felber stress the fact that BioLongevity Labs isn’t meant to be a replacement for traditional medical care. Instead, its products bridge the gap between clinical and extra-clinical care. There’s no magic pill or single solution to solve the problem of aging.

But thanks to the development of specialized peptides, bioregulators, and small molecules, we’re closer than we’ve ever been before.

Continue Reading

Trending